<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"><channel><title><![CDATA[Hong Kong/China M&A/Events]]></title><description><![CDATA[A read across of firm, indicative, and rumoured proposals/events in Hong Kong]]></description><link>https://hk.quiddityresearch.co</link><image><url>https://substackcdn.com/image/fetch/$s_!GHnX!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9937ddaa-d869-4822-928e-5808c000a535_184x184.png</url><title>Hong Kong/China M&amp;A/Events</title><link>https://hk.quiddityresearch.co</link></image><generator>Substack</generator><lastBuildDate>Sat, 09 May 2026 02:45:42 GMT</lastBuildDate><atom:link href="https://hk.quiddityresearch.co/feed" rel="self" type="application/rss+xml"/><copyright><![CDATA[Quiddity Investment Advisors]]></copyright><language><![CDATA[en]]></language><webMaster><![CDATA[quiddityresearch@substack.com]]></webMaster><itunes:owner><itunes:email><![CDATA[quiddityresearch@substack.com]]></itunes:email><itunes:name><![CDATA[Quiddity Research]]></itunes:name></itunes:owner><itunes:author><![CDATA[Quiddity Research]]></itunes:author><googleplay:owner><![CDATA[quiddityresearch@substack.com]]></googleplay:owner><googleplay:email><![CDATA[quiddityresearch@substack.com]]></googleplay:email><googleplay:author><![CDATA[Quiddity Research]]></googleplay:author><itunes:block><![CDATA[Yes]]></itunes:block><item><title><![CDATA[China Shengmu (1432): Conditional MGO To Launch At Month-End]]></title><description><![CDATA[Back on the 30th October 2025, China Modern Dairy (1117 HK) (CMD) entered into a conditional SPA to acquire a 1.28% in raw milk producer China Shengmu (1432 HK) (CSM).]]></description><link>https://hk.quiddityresearch.co/p/china-shengmu-1432-conditional-mgo</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/china-shengmu-1432-conditional-mgo</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Fri, 08 May 2026 01:08:28 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/69a9725b-c5bc-47cb-b7e4-ff18a59fea04_225x225.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Back on the 30th October 2025, <strong>China Modern Dairy (1117 HK)</strong> (CMD) entered into a conditional SPA to acquire a 1.28% in raw milk producer <strong>China Shengmu (1432 HK)</strong> (CSM).</p></li><li><p>As CMD then held 29.99% in CSM, the additional 1.28% clears 30%, obligating CMD to make a conditional Offer for all shares not held. The Offer Price will be A$0.35/share</p></li><li><p>The key SPA condition - SAMR clearance - is now satisfied. SPA completion expected on the 22nd May and Composite Doc dispatch on or before the 29th May.</p></li></ul><p><em><strong>China Shengmu Organic Milk (1432 HK) (CSM) is pretty illiquid. Look away now if this is not your bag.</strong></em></p><div><hr></div><p><strong>The Trade</strong>:</p><ul><li><p>Trading at a 9.4% gross spread.</p></li><li><p>I don&#8217;t have a strong conviction on the back-end.</p></li><li><p>Still, I&#8217;d be buying here - either for the arb (if you like illiquid arbs), or for the back-end on the assumption takes control of CSM.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/china-shengmu-1432-conditional-mgo">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Guoco (53 HK): Still Deep Value. Still Illiquid]]></title><description><![CDATA[I see Guoco Group Ltd (53 HK)&#8216;s implied stub at around a decade low.]]></description><link>https://hk.quiddityresearch.co/p/guoco-53-hk-still-deep-value-still</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/guoco-53-hk-still-deep-value-still</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Tue, 05 May 2026 02:42:14 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/a87da185-9020-42c8-9fba-161898493c33_378x133.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>I see <strong>Guoco Group Ltd (53 HK)</strong>&#8216;s implied stub at around a decade low. And a trailing P/B of 0.34x, versus the five-year average of 0.4x.</p></li><li><p>~67%-Held <strong>GuocoLand (GUOL SP)</strong> (trading at 0.64x P/B) looks set to privatise ~68%-held <strong>Guocoland Malaysia (GUOL MK)</strong> at ~0.55x P/B, further adding to Guoco&#8217;s look-through &#8220;cheapness&#8221;.</p></li><li><p>It&#8217;s coming up to eight years since the Quek family last attempted to take Guoco private. I can see the family stepping up here.</p></li></ul><p><em><strong>Guoco is super illiquid - look away now if this is not your bag</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>Guoco remains a potential privatisation play; and/or a deep value play.</p></li><li><p>I see the implied stub - net of the key listcos - around a decade low.</p></li><li><p>The look-through P/B is just 0.34x.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/guoco-53-hk-still-deep-value-still">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Tian An Medicare (383 HK)'s Partial Offer Doc Now Out]]></title><description><![CDATA[On the 23rd March, hospital/nursing home operator Tian An Medicare (383 HK) announced a small buyback, potentially lifting Tian An China Investment (28 HK)&#8216;s stake to 55% from 51.47%.]]></description><link>https://hk.quiddityresearch.co/p/tian-an-medicare-383-hks-partial</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/tian-an-medicare-383-hks-partial</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Wed, 29 Apr 2026 05:39:29 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/bdaafe8c-27f7-4e60-8486-463eac7ee9df_299x168.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>On the 23rd March, hospital/nursing home operator <strong>Tian An Medicare (383 HK)</strong> announced a small buyback, potentially lifting <strong>Tian An China Investment (28 HK)</strong>&#8216;s stake to 55% from 51.47%.</p></li><li><p>The buyback is for 70mn shares or 6.48% of shares out, at HK$1.10/share, a 15.79% premium to last close. <strong>IF</strong> key shareholders do not tender, pro-ration <em>could</em> be &gt;95%.</p></li><li><p><a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0427/2026042702170.pdf">The Offer Doc is now out</a>. The SGM (effectively a formality) will be held on the 18th May. The IFA says &#8220;<em>fair and reasonable</em>&#8220;.</p></li></ul><p><em><strong>Tian An Medicare is illiquid. Look away now if this is not your bag.</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>I&#8217;d buy Tian An Medicare, either for the back-end (if you have a strong opinion); or for what could potentially be a very high pro-ration.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/tian-an-medicare-383-hks-partial">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Ju Teng International (3336 HK): Possible Takeunder, IF An Offer Unfolds]]></title><description><![CDATA[Ju Teng International (3336 HK), a notebook-computer casing maker, is currently suspended pursuant to the Takeovers Code.]]></description><link>https://hk.quiddityresearch.co/p/ju-teng-international-3336-hk-possible</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/ju-teng-international-3336-hk-possible</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 23 Apr 2026 07:53:57 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/bbec8d92-0f1b-4d77-9507-bda0caf34658_225x225.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>Ju Teng International (3336 HK)</strong>, a notebook-computer casing maker, is currently suspended pursuant to the Takeovers Code.</p></li><li><p>Ju Teng, which hasn&#8217;t returned a profit since FY22, is up 92% since Mar-end, and 40% this week alone, on decent volume. Textbook news leak there. And perhaps short covering.</p></li><li><p>My bet is that the controlling shareholder, the Cheng family, are exiting. This or may, or may not, lead to a MGO/Scheme. IF an Offer unfolds, expect a takeunder.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/ju-teng-international-3336-hk-possible">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Changhong Jiahua (3991 HK): What's Up (Or Down To Be Precise)?]]></title><description><![CDATA[Back on the 22nd September 2025, SOE-backed Sichuan Changhong Electric Co, Ltd.]]></description><link>https://hk.quiddityresearch.co/p/changhong-jiahua-3991-hk-whats-up</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/changhong-jiahua-3991-hk-whats-up</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 23 Apr 2026 01:55:12 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/172c7c98-cf00-44f5-8b47-71a4703f05ce_232x142.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Back on the 22nd September 2025, SOE-backed <strong>Sichuan Changhong Electric Co, Ltd. (600839 CH)</strong> made an Offer, by way of a pre-conditional Scheme, for 60.13%-held <strong>Changhong Jiahua Holdings (3991 HK)</strong></p></li><li><p>Sichuan Changhong, plus provincial bodies,<strong> offered HK$1.223/share</strong>, a 32.93% premium to last close. The Offer Price is final. And optically is fair.</p></li><li><p>City level SASAC has been squared away. Provincial reg clearances outstanding (&amp; tardy), which <em>may</em> be due to governmental personnel changes, and the approval process straddling Chinese New Year.</p></li></ul><p><em><strong>Changhong Jiahua Holdings is super illiquid - look away now if this is not your bag.</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>My bet is that the reg delays are purely administrative, not any thorny issue.</p></li><li><p>CJ is illiquid. If an arb investor - or investors - opt to kick out, this will push the stock down, as it appears this week.</p></li><li><p>If small, illiquid arbs are your bag, I&#8217;d be taking advantage of the share price weakness here.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/changhong-jiahua-3991-hk-whats-up">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Yancoal (YAL AU) Retraces Post Kestrel Mine Deal]]></title><description><![CDATA[On the 14th April, Yancoal (YAL AU) announced it had entered into a transaction to acquire a majority stake in the Kestrel coal mine, located in Queensland, for &#8220;up to&#8221; US$2.4bn.]]></description><link>https://hk.quiddityresearch.co/p/yancoal-yal-au-retraces-post-kestrel</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/yancoal-yal-au-retraces-post-kestrel</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Mon, 20 Apr 2026 09:12:39 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/b33e6c77-2d19-4863-8b35-cf7da7981910_297x170.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>On the 14th April, <strong>Yancoal (YAL AU)</strong> <a href="https://announcements.asx.com.au/asxpdf/20260414/pdf/06yh1vf2g4rt14.pdf">announced</a> it had entered into a transaction to acquire a majority stake in the Kestrel coal mine, located in Queensland, for &#8220;up to&#8221; US$2.4bn.</p></li><li><p>Yancoal intends to acquire the 80% stake held by EMR Capital and <strong>Adaro Energy (ADRO IJ)</strong> JV. Mitsui will maintain its 20% stake.</p></li><li><p>80% of Kestrel was previously held by <strong>Rio Tinto Ltd (RIO AU)</strong>, and sold for A$2.25bn in 2018. That transaction required FIRB approval. This transaction also requires FIRB signing off.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/yancoal-yal-au-retraces-post-kestrel">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[CK Hutch (1 HK): The Optics Are Looking Favourable]]></title><description><![CDATA[CK Hutchison (1 HK)&#8216;s arbitration - with the Panama government AND Maersk - continues, with China&#8217;s full backing, over the (ostensibly) illegal confiscation of the Balboa and Cristobal ports.]]></description><link>https://hk.quiddityresearch.co/p/ck-hutch-1-hk-the-optics-are-looking</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/ck-hutch-1-hk-the-optics-are-looking</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Fri, 17 Apr 2026 02:05:58 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/12e0fc13-81af-4fa9-b84d-052b4b2ac643_200x200.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>CK Hutchison (1 HK)</strong>&#8216;s arbitration - with the Panama government AND Maersk - continues, with China&#8217;s full backing, over the (ostensibly) illegal confiscation of the Balboa and Cristobal ports.</p></li><li><p>Elsewhere, ongoing divestments are further stacking CKH&#8217;s cash pile, a development not lost on the three key rating agencies.</p></li><li><p>And CKH&#8217;s 16.7% stake in <strong>Cenovus Energy (CVE US)</strong>, already a strong cashflow generator, is a key standout from the ongoing Iran situation.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>At a ~49% discount to NAV and a forward P/B of 0.40x, CKH remain inexpensive.</p></li><li><p>Long-term, CKH remains a buy.</p></li></ul><p><em><strong>This insight is bullish - from a long-term investment point of view.</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/ck-hutch-1-hk-the-optics-are-looking">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Hang Lung (10 HK) Is Inexpensive As Dodge & Cox Sells (A Little)]]></title><description><![CDATA[Back in January 2024 HLP offered a scrip dividend option, and HLG has taken full advantage, increasing its stake by 4%.]]></description><link>https://hk.quiddityresearch.co/p/hang-lung-10-hk-is-inexpensive-as</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/hang-lung-10-hk-is-inexpensive-as</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 16 Apr 2026 02:01:54 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/f05bfe29-9373-477d-a1f7-6c789baf622f_800x533.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Back in January 2024 HLP offered a scrip dividend option, and HLG has taken full advantage, increasing its stake by 4%.</p></li><li><p>As HLG adds more HLP, long-term deep value play Dodge &amp; Cox gradually sells HLG. That makes things interesting. And HLG&#8217;s P/B is inexpensive.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>HLG remains dirt cheap at 0.23x P/B - albeit illiquid.</p></li><li><p>Expect HLG to continue to exercise its rights to HLP scrip and chip away at minorities. It does not need the cash.</p></li><li><p>I doubt there is some grand plan afoot - for either HLP or HLG. Dodge &amp; Cox selling HLG does, however, play into the Chan&#8217;s court.</p></li><li><p>I&#8217;d be getting some exposure in HLG.</p></li></ul><p><em><strong>This insight is labelled bullish, as I&#8217;m not bearish.</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/hang-lung-10-hk-is-inexpensive-as">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Evergrande Property Services (6666 HK): Signs Of Life In Liquidators’ Auction ]]></title><description><![CDATA[On the 11th September 2025, Evergrande Property Services (6666 HK) (EPS) announced that the liquidators for Evergrande (3333 HK) had been fielding non-binding Offers for Evergrande&#8217;s 51.016% stake in EPS.]]></description><link>https://hk.quiddityresearch.co/p/evergrande-property-services-6666-497</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/evergrande-property-services-6666-497</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Wed, 15 Apr 2026 02:30:31 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/756e39da-7a54-4856-b86d-b3c75d68d1e9_160x160.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>On the 11th September 2025, <strong>Evergrande Property Services (6666 HK)</strong> (EPS) <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0911/2025091101410.pdf">announced</a> that the liquidators for <strong>Evergrande (3333 HK)</strong> had been fielding non-binding Offers for Evergrande&#8217;s 51.016% stake in EPS.</p></li><li><p>Final proposals <em>were</em> expected to be submitted by November. Then (pretty much) crickets. FWIW, Evergrande was delisted from the HKEx on the 25th August 2025.</p></li><li><p>Yesterday, the same day Evergrande founder Hui Ka-yan plead guilty to fraud, EPS <a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0414/2026041400875.pdf">announced</a> Evergrande has entered into a 30 day exclusivity period with a mystery buyer.</p></li></ul><p><strong>The Trade</strong>:</p><ul><li><p>I wouldn&#8217;t chase it. Metrics are fair with respect to peers.</p></li><li><p>There is no shortage of choices in this space.</p></li><li><p>EPS is up 108% since Evergrande entered liquidation versus 5% for peers.</p></li></ul><p><em>This insight is still labelled bullish as I&#8217;m not bearish here. Challenging to gauge what a possible MGO price may be.</em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/evergrande-property-services-6666-497">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[ENN Energy (2688 HK) Is Still A Buy]]></title><description><![CDATA[It&#8217;s been a little over three months since NDRC, MoC, and SAFE cleared this transaction.]]></description><link>https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-still-a-buy</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-still-a-buy</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 09 Apr 2026 03:21:19 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/bafac79f-da02-44e6-a49e-260a1b5621b6_300x168.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>It&#8217;s been a little over three months since NDRC, MoC, <em>and</em> SAFE cleared this transaction. Only CSRC is outstanding.</p></li><li><p>For CSRC to pushback, it would need to clearly articulate, inter alia, clear friction points surrounding the deal structure (unfair share dilution) and/or systematic A-share market risks. Neither appears apparent.</p></li><li><p>The market is implying an unreasonable discount for ENN NG&#8217;s Hs vs. the As. I&#8217;d get involved.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>CSRC approval should be forthcoming</p></li><li><p>The delay may simply be a procedural one.</p></li><li><p>The market is implying an unreasonable discount for ENN NG&#8217;s Hs vs As.</p></li><li><p>A-share borrow is available.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-still-a-buy">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Rongzun (1780 HK): Halted Pursuant To Takeover’s Code]]></title><description><![CDATA[Construction contractor play Rongzun (1780 HK) is suspended pursuant to the Hong Kong Code on Takeovers and Mergers.]]></description><link>https://hk.quiddityresearch.co/p/rongzun-1780-hk-halted-pursuant-to</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/rongzun-1780-hk-halted-pursuant-to</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Wed, 08 Apr 2026 06:52:12 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/05f17104-f28d-4e2d-9341-fc78b0cc55e9_225x225.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Construction contractor play <strong>Rongzun (1780 HK) </strong>is suspended pursuant to the Hong Kong Code on Takeovers and Mergers.</p></li><li><p>I discussed Rongzun last November after the key shareholder placed out a 60% stake, leaving it with 15%.</p></li><li><p>The remaining 15% was sold on the 30th March, and Jingyao Yang emerged with 19.84%. Xia Liping, an INED at <strong>Future World Holdings (572 HK), </strong>also holds 13.71%.</p></li></ul><p><em><strong>Rongzun is illiquid - look away now if this is not your bag</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>Shares are currently suspended, so there is nothing to be done as yet.</p></li><li><p>I don&#8217;t see a full takeover (from Jingyao Yang) - not with the share price up 92% since he bought shares.</p></li><li><p>My bet is that Yang enters into a SPA, lifting his stake &gt;30%, triggering an MGO - possibly via a takeunder.</p></li></ul><p><em><strong>This insight is labelled bullish as it has to be labelled something</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/rongzun-1780-hk-halted-pursuant-to">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[BeijingWest Industries (2339 HK): Halted Pursuant To Takeover's Code]]></title><description><![CDATA[Auto components play BeijingWest Industries (2339 HK) is suspended pursuant to the Hong Kong Code on Takeovers and Mergers.]]></description><link>https://hk.quiddityresearch.co/p/beijingwest-industries-2339-hk-halted</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/beijingwest-industries-2339-hk-halted</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Wed, 08 Apr 2026 05:01:22 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/cf6c7f35-48c7-43bf-aa0d-9c29b7f4b5ed_225x225.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Auto components play <strong>BeijingWest Industries (2339 HK)</strong> is suspended pursuant to the Hong Kong Code on Takeovers and Mergers.</p></li><li><p>BeijingWest hasn&#8217;t returned a profit since FY19. Following a major restructuring (equity + CB) announced last November, primarily to shore up finances, the share price is up an eye-watering ~320%</p></li><li><p>A big part of that euphoric price rise was controlling shareholder SOE-backed BWI Beijing backstopping the restructuring. But a privatisation tilt here at ~5x P/B? Unlikely.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>Shares are currently suspended, so there is nothing to be done as yet.</p></li><li><p>Currently trading at 5x P/B. That&#8217;s a bubble.</p></li><li><p>I cannot see BWI Beijing launching a privatisation anywhere near this share price.</p></li><li><p>My bet is that BWI Beijing sells some shares - or the CB - to some third party.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/beijingwest-industries-2339-hk-halted">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Update On 3SBio (1530 HK)’s Spin-Off and Listing of Mandi]]></title><description><![CDATA[Back on the 20th November 2025, pharma-play 3SBio (1530 HK) announced the spin-off and listing of 87.16%-held Mandi, a &#8220;hair loss and weight management treatments&#8220; solutions provider, on the HKEx.]]></description><link>https://hk.quiddityresearch.co/p/update-on-3sbio-1530-hks-spin-off</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/update-on-3sbio-1530-hks-spin-off</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 02 Apr 2026 01:42:40 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/04f9da59-7e48-42f3-8f2f-774a9542f9b0_225x225.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Back on the 20th November 2025, pharma-play <strong>3SBio (1530 HK)</strong> announced the spin-off and listing of 87.16%-held Mandi, a &#8220;<em>hair loss and weight management treatments</em>&#8220; solutions provider, on the HKEx.</p></li><li><p>3SBio will distribute its stake in-specie, together with a concurrent global offering. An EGM has been set for the 23rd April for shareholders to vote on the in-specie distribution.</p></li><li><p>Mandi accounted for 17% of 3SBio&#8217;s revs in the 1H25, and 12.5% of profit. No updated figures for 2H25 have been provided. 3SBio&#8217;s overall FY25 numbers were stellar.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>Given the size of Mandi - relative to 3SBio - higher market multiples will have a limited impact on 3SBio&#8217;s overall valuation.</p></li><li><p>3SBio&#8217;s share price popped 12% yesterday following the release of strong FY25 numbers. However, the stock is down 22% from my last note.</p></li><li><p>My calcs suggest 3SBio is fairly valued here.</p></li></ul><p><em><strong>The insight is still labelled bullish as I&#8217;m not bearish 3SBio&#8217;s long-term value (although I don&#8217;t have a strong conviction here one way or another). I&#8217;m more bearish the spin-off will have any material impact on 3SBio.</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/update-on-3sbio-1530-hks-spin-off">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[ENN Energy (2688 HK) Is A Buy]]></title><description><![CDATA[We&#8217;ve now cleared the one-year mark since ENN Energy (2688 HK) first announced a cash/scrip Offer from controlling shareholder ENN Natural Gas (600803 CH) (ENN NG).]]></description><link>https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-a-buy</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-a-buy</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Tue, 31 Mar 2026 09:45:38 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/de2070ca-68e9-445b-9afc-31576434e30c_300x168.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>We&#8217;ve now cleared the one-year mark since <strong>ENN Energy (2688 HK)</strong> first announced a cash/scrip Offer from controlling shareholder <strong>ENN Natural Gas (600803 CH)</strong> (ENN NG).</p></li><li><p>Apart from the ambiguity surrounding the value to be assigned to the scrip into newly-listed ENN-NG H-shares; CSRC, the listing watchdog, has yet to sign off. This <em>should</em> be forthcoming.</p></li><li><p>By my calcs, I see at least 30% upside to ENN Energy&#8217;s shares here. The market is implying an unreasonable 67% discount for ENN NG&#8217;s Hs vs. the As.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>CSRC approval will not be an issue.</p></li><li><p>No matter how I play around with my calcs, I see considerable upside to ENN Energy shares here.</p></li><li><p>Plus the FY25 dividend of HK$2.35/share will (should) be added to terms.</p></li><li><p>The market appears to be implying an unrealistic discount for ENN NG&#8217;s Hs vs As.</p></li><li><p>From what I understand, A share borrow is available.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/enn-energy-2688-hk-is-a-buy">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[StubWorld: Shenzhen Int'l (152 HK) Trading "Cheap" To SZ E'way]]></title><description><![CDATA[Shenzhen International (152 HK) is coming up cheap to 47.3%-held subsidiary Shenzhen Expressway (600548 CH)/Shenzhen Expressway H (548 HK).]]></description><link>https://hk.quiddityresearch.co/p/stubworld-shenzhen-intl-152-hk-trading</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/stubworld-shenzhen-intl-152-hk-trading</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Fri, 27 Mar 2026 02:18:19 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/c2dc731e-ce52-4c6b-9d10-97e6e4e46e01_200x200.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>Shenzhen International (152 HK)</strong> is coming up cheap to 47.3%-held subsidiary <strong>Shenzhen Expressway (600548 CH)</strong>/<strong>Shenzhen Expressway H (548 HK)</strong>.</p></li></ul><div><hr></div><p><strong>The Trade</strong>:</p><ul><li><p><strong>Shenzhen International (152 HK)</strong> is often viewed as a proxy to <strong>Shenzhen Expressway (600548 CH)</strong>/<strong>Shenzhen Expressway Co H (548 HK)</strong>.</p></li><li><p>I feel I might be a tad late to the party after this recent move in SIHL.</p></li><li><p>Still, I&#8217;d prefer to be reversing the stub here - short SIHL, long 548.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/stubworld-shenzhen-intl-152-hk-trading">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Regal REIT (1881 HK) Is Dirt Cheap At 0.1x P/​B. Sells Asset At 0.8x P/​B.]]></title><description><![CDATA[Regal REIT (1881 HK) has announced it will sell the Regal Oriental Hotel in Kowloon City to Blue Sky Properties (owned by Centaline) for HK$1.51bn (gross proceeds).]]></description><link>https://hk.quiddityresearch.co/p/regal-reit-1881-hk-is-dirt-cheap</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/regal-reit-1881-hk-is-dirt-cheap</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Tue, 24 Mar 2026 06:35:28 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/9e76bd61-6bfe-4d3b-8cb7-a216ed4b0fb7_259x194.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>Regal REIT (1881 HK)</strong> has announced it will sell the Regal Oriental Hotel in Kowloon City to Blue Sky Properties (owned by Centaline) for HK$1.51bn (gross proceeds).</p></li><li><p>Centaline intends to convert the hotel into a student hostel once the necessary government approvals have been satisfied.</p></li><li><p>Even with a haircut to book - ~0.8x P/B by my calcs - this sale is a win for Regal REIT, currently trading at 0.1x P/B.</p></li></ul><p><em><strong>Regal REIT (1881 HK) is super illiquid. Look away now if this is not your bag.</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>Liquidity is a major issue.</p></li><li><p>Given the bombed out P/Bs, now seems an opportune time for Lo Yuk-sui to privatise companies up &amp; down the vertical holding structure.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/regal-reit-1881-hk-is-dirt-cheap">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Chifeng Jilong Gold (6693 HK): Zijin Mining Seeks Controlling Stake]]></title><description><![CDATA[Zijin Mining Group (2899 HK) is seeking to become the largest shareholder in dual-listed (and currently privately-owned) Chifeng Jilong Gold Mining (6693 HK).]]></description><link>https://hk.quiddityresearch.co/p/chifeng-jilong-gold-6693-hk-zijin</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/chifeng-jilong-gold-6693-hk-zijin</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Tue, 24 Mar 2026 03:51:57 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/3f80d4bb-8921-4bd4-9676-bc95b73070ee_225x225.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>Zijin Mining Group (2899 HK)</strong> is seeking to become the largest shareholder in dual-listed (and currently privately-owned) <strong>Chifeng Jilong Gold Mining (6693 HK)</strong>.</p></li><li><p>Zijin Mining&#8217;s subsidiary, Zijin Gold (not the listco), will buy 242mnn A shares of Chifeng Gold from its single largest shareholder, Li Jinyang, and concert party Zhejiang Hanfeng, at RMB41.36/share.</p></li><li><p>Concurrently, Zijin Gold has proposed subscribing to 311mn new H shares of Chifeng Gold at HK$30.19/share. If all goes to plan, Zijin Mining will hold 25.85% in Chifeng Gold.</p></li></ul><p><strong>The Trade</strong>:</p><ul><li><p>Depending on your gold viewpoint, the consolidation of resources and output is, to me, positive amid ongoing geopolitical tensions and safe-haven demand.</p></li></ul><p><em><strong>This insight is labelled bullish as I&#8217;m not bearish Chifeng here.</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/chifeng-jilong-gold-6693-hk-zijin">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[Tian An Medicare (383 HK): Small But Interesting Buyback]]></title><description><![CDATA[Hospital and nursing home operator Tian An Medicare (383 HK) has announced a small buyback, which could potentially lift Tian An China Investment (28 HK)&#8216;s stake to 55% from 51.47%.]]></description><link>https://hk.quiddityresearch.co/p/tian-an-medicare-383-hk-small-but</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/tian-an-medicare-383-hk-small-but</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Tue, 24 Mar 2026 01:31:22 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/24556b2a-3722-4495-aa19-d2ee64f446e2_299x168.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p>Hospital and nursing home operator <strong>Tian An Medicare (383 HK)</strong> has announced a small buyback, which could potentially lift <strong>Tian An China Investment (28 HK)</strong>&#8216;s stake to 55% from 51.47%.</p></li><li><p>The buyback is for 70mn shares or 6.48% of shares out, at HK$1.10/share, a 15.79% premium to last close. <strong>IF</strong> key shareholders do not tender, pro-ration <em>could</em> be &gt;95%.</p></li><li><p>The only condition is an ordinary resolution at an SGM, and no shareholder need abstain. Which means the vote is a formality. I&#8217;m surprised it even needs to take place.</p></li></ul><p><em><strong>Tian An Medicare is illiquid. Look away now if this is not your bag.</strong></em></p><div><hr></div><p><strong>The Trade:</strong></p><ul><li><p>I&#8217;d buy Tian An Medicare, either for the back-end (if you have a strong opinion); or for what could potentially be a very high pro-ration.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/tian-an-medicare-383-hk-small-but">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[CK Hutchison (1 HK): "New And Perhaps Unforeseen Challenges"]]></title><description><![CDATA[CK Hutchison Holdings (1 HK) has announced a 7% increase in underlying profit in 2025 of HK$22.3bn.]]></description><link>https://hk.quiddityresearch.co/p/ck-hutchison-1-hk-new-and-perhaps</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/ck-hutchison-1-hk-new-and-perhaps</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Fri, 20 Mar 2026 01:36:13 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/a6ad939d-b938-40c6-bc65-3e02a39a42b0_200x200.jpeg" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>CK Hutchison Holdings (1 HK)</strong> has announced a 7% increase in underlying profit in 2025 of HK$22.3bn.</p></li><li><p>Factoring in a one-off &#8288;non-cash loss of HK$10.9bn relating to the UK telcos merger of 3UK with Vodafone, net profit declined &#8288;31% to HK$11.8bn.</p></li><li><p>Chairman Victor Li Tzar-kuoi added the group&#8217;s businesses will face &#8220;<em>new and perhaps unforeseen challenges in 2026</em>&#8220;; and is under &#8220;<em>absolutely no pressure</em>&#8221; to sell any assets.</p></li></ul><p><strong>The Trade:</strong></p><ul><li><p>At a ~53% discount to NAV and a forward P/B of 0.40x, CKH is inexpensive.</p></li><li><p>Near term, expect CKH to drift sideways. Longer-term, this remains a buy.</p></li><li><p>Overhangs include ongoing geopolitical and regulatory scrutiny; together with Middle East instability.</p></li></ul><p><em><strong>This insight is bullish - from a long-term investment point of view.</strong></em></p>
      <p>
          <a href="https://hk.quiddityresearch.co/p/ck-hutchison-1-hk-new-and-perhaps">
              Read more
          </a>
      </p>
   ]]></content:encoded></item><item><title><![CDATA[StubWorld: Cathay Air Outperforming Air China; And WH Group Outperforming Smithfield]]></title><description><![CDATA[Cathay Pacific Airways (293 HK)&#8216;s recent outperformance is predicted on a (perceived) greater flexibility to shift capacity/routes versus Air China Ltd (A) (601111 CH), and proportionately less Middle East exposure.]]></description><link>https://hk.quiddityresearch.co/p/stubworld-cathay-air-outperforming</link><guid isPermaLink="false">https://hk.quiddityresearch.co/p/stubworld-cathay-air-outperforming</guid><dc:creator><![CDATA[Quiddity Research]]></dc:creator><pubDate>Thu, 19 Mar 2026 02:23:27 GMT</pubDate><enclosure url="https://substack-post-media.s3.amazonaws.com/public/images/e2d4f50d-7728-4e55-b032-1ca4d17480ae_300x168.png" length="0" type="image/jpeg"/><content:encoded><![CDATA[<ul><li><p><strong>Cathay Pacific Airways (293 HK)</strong>&#8216;s recent outperformance is predicted on a (perceived) greater flexibility to shift capacity/routes versus <strong>Air China Ltd (A) (601111 CH)</strong>, and proportionately less Middle East exposure.</p></li></ul>
      <p>
          <a href="https://hk.quiddityresearch.co/p/stubworld-cathay-air-outperforming">
              Read more
          </a>
      </p>
   ]]></content:encoded></item></channel></rss>